Follow
Anne-Bine Skytte
Anne-Bine Skytte
KEA
Verified email at clin.au.dk
Title
Cited by
Cited by
Year
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
6642013
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
5902015
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ...
Journal of clinical oncology 38 (7), 674-685, 2020
4132020
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ...
PLoS genetics 9 (3), e1003212, 2013
3432013
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ...
Human mutation 39 (5), 593-620, 2018
3332018
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
3202015
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ...
European urology 66 (3), 489-499, 2014
3052014
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ...
Journal of Clinical Oncology 35 (20), 2240-2250, 2017
1992017
The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1
M Depner, S Fuchs, J Raabe, N Frede, C Glocker, R Doffinger, ...
Journal of clinical immunology 36, 73-84, 2016
1582016
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of …
AM Mulligan, FJ Couch, D Barrowdale, SM Domchek, D Eccles, ...
Breast Cancer Research 13, 1-20, 2011
1422011
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers
AC Antoniou, KB Kuchenbaecker, P Soucy, J Beesley, X Chen, ...
Breast Cancer Research 14, 1-18, 2012
1212012
Risk‐reducing mastectomy and salpingo‐oophorectomy in unaffected BRCA mutation carriers: uptake and timing*
AB Skytte, AM Gerdes, MK Andersen, L Sunde, K Brøndum‐Nielsen, ...
Clinical genetics 77 (4), 342-349, 2010
1192010
Breast cancer after bilateral risk‐reducing mastectomy
AB Skytte, D Crüger, M Gerster, AV Lænkholm, C Lang, ...
Clinical genetics 79 (5), 431-437, 2011
882011
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation …
FJ Couch, MM Gaudet, AC Antoniou, SJ Ramus, KB Kuchenbaecker, ...
Cancer epidemiology, biomarkers & prevention 21 (4), 645-657, 2012
752012
Multilocus inherited neoplasia alleles syndrome: a case series and review
J Whitworth, AB Skytte, L Sunde, DH Lim, MJ Arends, L Happerfield, ...
JAMA oncology 2 (3), 373-379, 2016
682016
Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes
J Whitworth, PS Smith, JE Martin, H West, A Luchetti, F Rodger, G Clark, ...
The American Journal of Human Genetics 103 (1), 3-18, 2018
652018
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
SJ Ramus, AC Antoniou, KB Kuchenbaecker, P Soucy, J Beesley, X Chen, ...
Human mutation 33 (4), 690-702, 2012
652012
Estimating the effect size of the 15Q11. 2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice
AE Jønch, E Douard, C Moreau, A Van Dijck, M Passeggeri, F Kooy, ...
Journal of Medical Genetics 56 (10), 701-710, 2019
602019
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
VL Patel, EL Busch, TM Friebel, A Cronin, G Leslie, L McGuffog, J Adlard, ...
Cancer research 80 (3), 624-638, 2020
552020
Dosage changes of a segment at 17p13. 1 lead to intellectual disability and microcephaly as a result of complex genetic interaction of multiple genes
CMB Carvalho, S Vasanth, M Shinawi, C Russell, MB Ramocki, ...
The American Journal of Human Genetics 95 (5), 565-578, 2014
512014
The system can't perform the operation now. Try again later.
Articles 1–20